• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Fractyl Health

Fractyl Health

Transformative Metabolic Therapies

  • Investors
  • Clinical Studies
  • Careers
  • Our Focus
    • Obesity
    • Type 2 Diabetes
  • Our Platforms
    • Revita
    • Rejuva
  • Our Science
    • Clinical Studies
    • Presentations & Publications
  • Our Company
    • Culture
    • Our Team
    • Careers
  • Our News
    • Media Kit
Home/Publication

Duodenal mucosal resurfacing combined with GLP-1RA to discontinue insulin in type 2 diabetes: a feasibility study

Publication

December 28, 2020 by

October 28, 2020 by

January 28, 2020 by

November 28, 2019 by

October 28, 2019 by

April 28, 2017 by

September 28, 2016 by

August 28, 2016 by

  • « Go to Previous Page
  • Page 1
  • Page 2

Footer

LinkedIn X, formally Twitter Facebook
© 2014-2024 Fractyl Health, Inc. All Rights Reserved.
  • Contact
  • Privacy & Cookie Policy
  • Terms of Use
  • Intellectual Property
  • Transparency in Coverage
logo
  • Our Focus
    • Obesity
    • Type 2 Diabetes
  • Our Platforms
    • Revita
    • Rejuva
  • Our Science
    • Clinical Studies
    • Presentations & Publications
  • Our Company
    • Culture
    • Our Team
    • Careers
  • Our News
    • Media Kit
  • Investors